Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions

Ulcerative ColitisInflammatory Bowel Diseases

Trial Locations (1)

Nancy University Hospital, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT06449820 - Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis | Biotech Hunter | Biotech Hunter